Search results for "allergic"

showing 10 items of 307 documents

Allergic contact dermatitis in patients with frontal fibrosing alopecia: An international multi‐center study

2020

Frontal fibrosing alopecia (FFA) mainly affects the anterior hairline and eyebrows and its etiology and associated factors remain obscure. The aim of this study was to evaluate the allergic contact dermatitis with patch test in patients with FFA. In this prospective study, 20 patients with FFA and 24 age and sex-matched healthy individuals were evaluated with patch testing. Diagnosis was made histologically, clinically and based on dermoscopic findings. Demographic data, age of onset, disease duration and FFA severity index are evaluated in all patients. Positive patch test reaction to one or more allergen was observed in 65% of patients while it was 37.5% in control group (P = .003). There…

medicine.medical_specialtyDermatologymedicine.disease_cause030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAllergenQuality of lifemedicineHumansProspective StudiesProspective cohort studyAllergic contact dermatitisbusiness.industryFrontal fibrosing alopeciaLichen PlanusPatch testAlopeciaGeneral Medicinemedicine.diseaseDermatology030220 oncology & carcinogenesisDermatitis Allergic ContactQuality of LifeEtiologyAge of onsetbusinessDermatologic Therapy
researchProduct

Allergic Contact Dermatitis to Benzocaine: The Importance of Concomitant Positive Patch Test Results

2013

Local anesthetics are widely used in clinical practice, and adverse effects are not uncommon. Delayed hypersensitivity reactions are among the most common effects, but immediate-type reactions may also occur. Patch testing should be considered in patients with hypersensitivity reactions. We present a case of allergic contact dermatitis to benzocaine that was detected incidentally by patch testing and highlight the importance of correctly interpreting patch test results when there are concomitant positive reactions.

medicine.medical_specialtyHistologybusiness.industryPatch testDermatologymedicine.diseaseDermatologyPathology and Forensic MedicineClinical PracticeBenzocaineDelayed hypersensitivityAnesthesiaConcomitantmedicineIn patientbusinessAdverse effectAllergic contact dermatitismedicine.drugActas Dermo-Sifiliográficas (English Edition)
researchProduct

Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.

2015

IMPORTANCE: Randomized clinical trials (RCTs) and meta-analyses of sublingual immunotherapy (SLIT) for the treatment of seasonal allergic rhinoconjunctivitis (SARC) have shown a modest clinical benefit compared with placebo. Furthermore, indirect comparison by meta-analyses showed that subcutaneous immunotherapy is more effective than SLIT. Despite these data, SLIT has become the most prescribed treatment of SARC in Europe in recent years, and it was approved by the US Food and Drug Administration for the treatment of SARC to grass pollen in the United States on April 1, 2014. OBJECTIVE: To assess the efficacy and safety of the grass pollen sublingual tablets licensed as drugs in the treatm…

medicine.medical_specialtyMEDLINECochrane LibraryPlaceboPlant Extractlaw.inventionRandomized controlled triallawInternal medicineInternal MedicinemedicineClinical endpointmedia_common.cataloged_instanceHumansEuropean unionAdverse effectmedia_commonConjunctivitis AllergicSublingual Immunotherapybusiness.industryPlant ExtractsAllergenMedicine (all)Rhinitis Allergic SeasonalAllergensAntigens PlantMeta-analysisImmunologybusinessHumanJAMA internal medicine
researchProduct

The concentration of para-phenylenediamine (PPD) for routine patch testing in a standard series needs to be redefined

2005

medicine.medical_specialtyPediatricsDose-Response Relationship Drugbusiness.industryDermatologyPatch TestsPhenylenediaminesPara phenylenediamineDermatologyPatch testing030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineGermany030220 oncology & carcinogenesisDermatitis Allergic ContactmedicineHumansImmunology and AllergyColoring AgentsbusinessContact Dermatitis
researchProduct

Very late reactions in the patch test with fragrance mix I and oak moss absolute (Evernia prunastri, INCI): Data of the Information Network of Depart…

2022

medicine.medical_specialtyTime Factors610 Medicine & healthDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineActive sensitizationmedicineImmunology and AllergyHumansddc:610610 Medicine & healthFragrance mixAllergic contact dermatitisbiologybusiness.industryParmeliaceaePatch testAbsolute (perfumery)AllergensPatch Testsmedicine.diseasebiology.organism_classificationMossDermatology030228 respiratory systemOdorantsbusiness
researchProduct

Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data.

2020

medicine.medical_specialtyUrticariabusiness.industryDermatologyGeneral MedicineOmalizumabOmalizumabReal world evidenceTreatment Outcomeclinical evaluation and treatmentAnti-Allergic AgentsChronic DiseasemedicineHumansChronic UrticariaIntensive care medicinebusinessdermatologic therapymedicine.drugPreliminary DataDermatologic therapyREFERENCES
researchProduct

Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentratio…

2015

Background: OMA is an effective treatment option in SAA. However, little data are available on the long-term-efficacy oft the drug. Objective: To determine the long-term efficacy of OMA in respect to clinical parameters and IgE serum levels. Methods: This was a retrospective, open-label, uncontrolled, multi-center observational study according to the definition of non-interventional studies. 22 non-smoking patients (10 m, 12 f; mean age 47,9 yrs) with SAA were enrolled. Pat were treated with OMA up to for 4 years and total serum IgE levels were assessed at initiation of therapy, after 2-6 ms and 3-5 yrs. Data were recorded on standardized CRFs by the treating physician. Results: The average…

medicine.medical_specialtybiologybusiness.industryAllergic asthmaAtopic dermatitisOmalizumabImmunoglobulin Emedicine.diseaseGastroenterologyTreatment periodSerum igeFood allergyInternal medicineConcomitantImmunologybiology.proteinmedicinebusinessmedicine.drug5.3 Allergy and Immunology
researchProduct

Recommendations for photopatch testing by the Photopatch Test Working Group of the German Contact Dermatitis Research Group (DKG).

2018

medicine.medical_specialtybusiness.industryDermatitis PhotoallergicPhotopatch testDermatologyPatch Testsmedicine.diseaseDermatologylanguage.human_languageGerman030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineGroup (periodic table)030220 oncology & carcinogenesislanguageMedicineHumansbusinessContact dermatitisJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
researchProduct

Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis–based comparison

2012

Background: Subcutaneous (SCIT) and sublingual (SLIT) immunotherapy are the 2 most prescribed routes for administering allergen-specific immunotherapy. They were shown to be effective in control of symptoms and in reducing rescue medication use in patients with allergic diseases, but their effectiveness has to be balanced against side effects. In recent years, SLIT has been increasingly prescribed, instead of SCIT, because of improved safety and easy administration. Objective: We assessed which route is the most effective in the treatment of patients with seasonal allergic rhinitis to grass pollen. Methods: An indirect meta-analysis–based comparison between SCIT and SLIT was performed. Trea…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentImmunologySublingual immunotherapy subcutaneous immunotherapy allergic rhinitis grass meta-analysisPlaceboSlitlaw.inventionSettore MED/01 - Statistica MedicaRandomized controlled trialStrictly standardized mean differencelawMeta-analysisInternal medicineImmunologymedicineImmunology and AllergySublingual immunotherapybusinessAdverse effectDesensitization (medicine)
researchProduct

Bafetinib inhibits functional responses of human eosinophils in vitro

2012

Eosinophils play a prominent role in the process of allergic inflammation. Non-receptor associated Lyn tyrosine kinases generate key initial signals in eosinophils. Bafetinib, a specific Abl/Lyn tyrosine kinase inhibitor has shown a potent antiproliferative activity in leukemic cells, but its effects on eosinophils have not been reported. Therefore, we studied the effects of bafetinib on functional and mechanistic responses of isolated human eosinophils. Bafetinib was more potent than non-specific tyrosin kinase comparators genistein and tyrphostin inhibiting superoxide anion triggered by N-formyl-Met-Leu-Phe (fMLF; 100 nM) (−log IC50=7.25±0.04 M; 6.1±0.04 M; and 6.55±0.03 M, respectively).…

medicine.medical_specialtymedicine.drug_classFarmacologíaGenisteinApoptosisPharmacologyBiologyTyrosine-kinase inhibitorAllergic inflammationchemistry.chemical_compoundCell MovementSuperoxidesLYNInternal medicinemedicineHumansProtein Kinase InhibitorsPeroxidasePharmacologyKinaseEosinophil Cationic ProteinGranulocyte-Macrophage Colony-Stimulating FactorEosinophilLeukotriene C4Respiratory burstEosinophilsN-Formylmethionine Leucyl-PhenylalaninePyrimidinesmedicine.anatomical_structureEndocrinologychemistryCalciumInterleukin-5Tyrosine kinaseEuropean Journal of Pharmacology
researchProduct